+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bleeding Disorders Treatment Market by Product Type (Anti Fibrinolytics, Clotting Factors, Desmopressin), Treatment Type (On Demand, Prophylactic), Route Of Administration, End Users, Distribution Channel, Disease Indication - Global Forecast 2025-2030- Product Image
Bleeding Disorders Treatment Market by Product Type (Anti Fibrinolytics, Clotting Factors, Desmopressin), Treatment Type (On Demand, Prophylactic), Route Of Administration, End Users, Distribution Channel, Disease Indication - Global Forecast 2025-2030- Product Image
Sale

Bleeding Disorders Treatment Market by Product Type (Anti Fibrinolytics, Clotting Factors, Desmopressin), Treatment Type (On Demand, Prophylactic), Route Of Administration, End Users, Distribution Channel, Disease Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010944
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bleeding Disorders Treatment Market is evolving rapidly as innovation reshapes clinical protocols, patient engagement, and delivery models. Senior decision-makers face a shifting ecosystem influenced by technological advances, value-based care trends, and a dynamic regulatory environment.

Market Snapshot: Bleeding Disorders Treatment Market Overview

The Bleeding Disorders Treatment Market grew from USD 14.80 billion in 2024 to USD 16.24 billion in 2025. It is expected to continue growing at a CAGR of 9.32%, reaching USD 25.28 billion by 2030.

Scope & Segmentation

This comprehensive report covers the global landscape and is designed to equip senior leaders with clarity on market structure, segment relevance, and emerging directions. The study assesses:

  • Product Types: Anti fibrinolytics, clotting factors (plasma derived, recombinant), and desmopressin.
  • Treatment Types: On demand and prophylactic approaches.
  • Routes of Administration: Intravenous, oral, and subcutaneous options.
  • End Users: Home care settings, hospitals, specialty clinics.
  • Distribution Channels: E-commerce, hospital, and retail pharmacies.
  • Disease Indications: Hemophilia A, hemophilia B, von Willebrand disease.
  • Regions Covered: Americas (including major U.S. states), Europe, Middle East & Africa (select markets), Asia-Pacific (key growth economies).
  • Key Companies Analyzed: CSL Limited, Grifols, Takeda, Octapharma, Bayer, Novo Nordisk, Roche, Pfizer, Sanofi, and Swedish Orphan Biovitrum AB.
  • Technologies Considered: Gene therapy, RNA-based therapeutics, digital health platforms, remote monitoring tools, and contract manufacturing partnerships.

Key Takeaways for Senior Decision-Makers

  • Breakthroughs in molecular and biotechnological innovation are transforming how bleeding disorders are managed, particularly with the rise of precision medicine and gene therapies.
  • Adoption of digital health and remote monitoring is advancing proactive intervention and patient adherence, supporting decentralized and home-based care models.
  • Strategic alliances between research institutions, biotech firms, and pharmaceutical leaders are accelerating clinical development and adaptation to emerging payer frameworks.
  • Differentiation is driven by extended half-life clotting factors and novel therapeutic agents, facilitating fewer infusions and improved treatment experiences.
  • The market’s evolution is marked by a strong focus on patient-centric delivery, operational agility, and alignment with value-based reimbursement practices.
  • Regional disparities highlight the necessity for tailored strategies, with growth in Asia-Pacific supported by expanded healthcare infrastructure and localization of manufacturing.

Tariff Impact: Addressing 2025 United States Biologics Tariff Adjustments

New U.S. tariffs on imported biologics in 2025 are driving manufacturers to review sourcing and cost structures. The introduction of these tariffs catalyzes shifts toward local production and strategic partnerships with regional manufacturing organizations. Distributors and specialty pharmacies are facing narrower margins, intensifying negotiations and encouraging a shift toward direct-to-patient distribution models. Regulatory stakeholders are expediting biosimilar reviews and domestic manufacturing capacity to mitigate potential supply disruptions. These factors collectively enhance supply chain resilience and prompt organizations to optimize sourcing and logistics while maintaining equitable access.

Research Methodology & Data Sources

This report is built on a mixed-methods framework. Primary research comprises interviews with hematologists, regulatory experts, patient advocates, and senior industry executives. Secondary data stems from peer-reviewed publications, clinical trial registries, health authority white papers, and formal policy documents. Triangulation and expert workshops underpin validation. Robust controls and ethical standards guide every stage.

Why This Report Matters

  • Enables leadership teams to make informed decisions on market entry, technology adoption, and investment in bleeding disorders treatment strategies.
  • Delivers actionable insights on evolving patient needs, regulatory shifts, and best practices for supply chain resilience.
  • Supports competitive benchmarking among leading companies, streamlining strategic planning and partnership evaluation in complex markets.

Conclusion

Advancements in bleeding disorders treatment are fundamentally altering care delivery and patient outcomes. Forward-thinking organizations that align innovation, operational agility, and strategic partnerships will secure a sustainable edge. This report provides the necessary clarity for making impactful, future-ready decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancement of bespoke AAV gene therapy platforms optimizing hemophilia A outcomes
5.2. Emergence of bispecific monoclonal antibodies for non-factor hemostatic management in hemophilia
5.3. Adoption of digital health platforms enabling remote monitoring of clotting factor levels
5.4. Growth of extended half-life recombinant factor concentrates decreasing treatment burden
5.5. Integration of pharmacokinetic-tailored dosing regimens improving prophylaxis adherence in hemophilia
5.6. Development of novel oral anticoagulant reversal agents for emergent bleeding management
5.7. Expansion of gene editing approaches using CRISPR technology to correct coagulation factor deficiencies
5.8. Growing emphasis on value-based agreements for high-cost hemophilia therapies in reimbursement discussions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bleeding Disorders Treatment Market, by Product Type
8.1. Introduction
8.2. Anti Fibrinolytics
8.3. Clotting Factors
8.3.1. Plasma Derived
8.3.2. Recombinant
8.4. Desmopressin
9. Bleeding Disorders Treatment Market, by Treatment Type
9.1. Introduction
9.2. On Demand
9.3. Prophylactic
10. Bleeding Disorders Treatment Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
10.4. Subcutaneous
11. Bleeding Disorders Treatment Market, by End Users
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Bleeding Disorders Treatment Market, by Distribution Channel
12.1. Introduction
12.2. E Commerce
12.3. Hospital Pharmacy
12.4. Retail Pharmacy
13. Bleeding Disorders Treatment Market, by Disease Indication
13.1. Introduction
13.2. Hemophilia A
13.3. Hemophilia B
13.4. Von Willebrand Disease
14. Americas Bleeding Disorders Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bleeding Disorders Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bleeding Disorders Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CSL Limited
17.3.2. Grifols, S.A.
17.3.3. Takeda Pharmaceutical Company Limited
17.3.4. Octapharma AG
17.3.5. Bayer AG
17.3.6. Novo Nordisk A/S
17.3.7. F. Hoffmann-La Roche Ltd
17.3.8. Pfizer Inc.
17.3.9. Sanofi S.A.
17.3.10. Swedish Orphan Biovitrum AB (publ)
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BLEEDING DISORDERS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BLEEDING DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BLEEDING DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BLEEDING DISORDERS TREATMENT MARKET: RESEARCHAI
FIGURE 28. BLEEDING DISORDERS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. BLEEDING DISORDERS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. BLEEDING DISORDERS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLEEDING DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTI FIBRINOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTI FIBRINOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ON DEMAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ON DEMAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 96. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 97. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 99. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 102. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 103. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 116. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 188. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 189. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 192. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 202. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 203. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 206. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 221. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 224. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 225. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 230. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 231. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 234. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 244. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 245. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 248. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 291. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY CLOTTING FACTORS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 300. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 301. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Bayer AG
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi S.A.
  • Swedish Orphan Biovitrum AB (publ)

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.28 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bleeding Disorders Treatment - Global Strategic Business Report - Product Image

Bleeding Disorders Treatment - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Bleeding Disorder Testing Market Report 2025 - Product Image

Bleeding Disorder Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bleeding Disorders Treatment Market Report and Forecast 2025-2034 - Product Image

Bleeding Disorders Treatment Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Bleeding Disorders Treatment Market Report 2025 - Product Image

Bleeding Disorders Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bleeding Disorder Diagnostics Market by Product Type (Instruments, Reagents, Services), Technology (Chromogenic Assays, Immunoassays, Molecular Diagnostics), End User, Application, Disease Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Bleeding Disorder Diagnostics Market by Product Type (Instruments, Reagents, Services), Technology (Chromogenic Assays, Immunoassays, Molecular Diagnostics), End User, Application, Disease Type - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global, United States Global, United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.